151 related articles for article (PubMed ID: 28766215)
1. The Androgen Receptor: Is It a Promising Target?
Gucalp A; Traina TA
Ann Surg Oncol; 2017 Oct; 24(10):2876-2880. PubMed ID: 28766215
[TBL] [Abstract][Full Text] [Related]
2. Role of the androgen receptor in triple-negative breast cancer.
Rampurwala M; Wisinski KB; O'Regan R
Clin Adv Hematol Oncol; 2016 Mar; 14(3):186-93. PubMed ID: 27058032
[TBL] [Abstract][Full Text] [Related]
3. Harnessing a Different Dependency: How to Identify and Target Androgen Receptor-Positive Versus Quadruple-Negative Breast Cancer.
Christenson JL; Trepel JB; Ali HY; Lee S; Eisner JR; Baskin-Bey ES; Elias AD; Richer JK
Horm Cancer; 2018 Apr; 9(2):82-94. PubMed ID: 29340907
[TBL] [Abstract][Full Text] [Related]
4. Androgen Receptor Biology in Triple Negative Breast Cancer: a Case for Classification as AR+ or Quadruple Negative Disease.
Barton VN; D'Amato NC; Gordon MA; Christenson JL; Elias A; Richer JK
Horm Cancer; 2015 Dec; 6(5-6):206-13. PubMed ID: 26201402
[TBL] [Abstract][Full Text] [Related]
5. The role of the androgen receptor in triple-negative breast cancer.
Shah PD; Gucalp A; Traina TA
Womens Health (Lond); 2013 Jul; 9(4):351-60. PubMed ID: 23826776
[TBL] [Abstract][Full Text] [Related]
6. Androgen receptor signaling pathways as a target for breast cancer treatment.
Pietri E; Conteduca V; Andreis D; Massa I; Melegari E; Sarti S; Cecconetto L; Schirone A; Bravaccini S; Serra P; Fedeli A; Maltoni R; Amadori D; De Giorgi U; Rocca A
Endocr Relat Cancer; 2016 Oct; 23(10):R485-98. PubMed ID: 27528625
[TBL] [Abstract][Full Text] [Related]
7. The Role of the Androgen Receptor Signaling in Breast Malignancies.
Christopoulos PF; Vlachogiannis NI; Vogkou CT; Koutsilieris M
Anticancer Res; 2017 Dec; 37(12):6533-6540. PubMed ID: 29187427
[TBL] [Abstract][Full Text] [Related]
8. Androgen Receptor Function and Androgen Receptor-Targeted Therapies in Breast Cancer: A Review.
Kono M; Fujii T; Lim B; Karuturi MS; Tripathy D; Ueno NT
JAMA Oncol; 2017 Sep; 3(9):1266-1273. PubMed ID: 28301631
[TBL] [Abstract][Full Text] [Related]
9. Androgen receptor in triple negative breast cancer.
McNamara KM; Yoda T; Takagi K; Miki Y; Suzuki T; Sasano H
J Steroid Biochem Mol Biol; 2013 Jan; 133():66-76. PubMed ID: 22982153
[TBL] [Abstract][Full Text] [Related]
10. Triple-negative breast cancer: role of the androgen receptor.
Gucalp A; Traina TA
Cancer J; 2010; 16(1):62-5. PubMed ID: 20164692
[TBL] [Abstract][Full Text] [Related]
11. A highly potent PROTAC androgen receptor (AR) degrader ARD-61 effectively inhibits AR-positive breast cancer cell growth in vitro and tumor growth in vivo.
Zhao L; Han X; Lu J; McEachern D; Wang S
Neoplasia; 2020 Oct; 22(10):522-532. PubMed ID: 32928363
[TBL] [Abstract][Full Text] [Related]
12. Androgen receptor expression in breast cancer: Implications on prognosis and treatment, a brief review.
Jahan N; Jones C; Rahman RL
Mol Cell Endocrinol; 2021 Jul; 531():111324. PubMed ID: 34000352
[TBL] [Abstract][Full Text] [Related]
13. Newly Developed Targeted Therapies Against the Androgen Receptor in Triple-Negative Breast Cancer: A Review.
Choupani E; Mahmoudi Gomari M; Zanganeh S; Nasseri S; Haji-Allahverdipoor K; Rostami N; Hernandez Y; Najafi S; Saraygord-Afshari N; Hosseini A
Pharmacol Rev; 2023 Mar; 75(2):309-327. PubMed ID: 36781219
[TBL] [Abstract][Full Text] [Related]
14. Androgen Receptor in Breast Cancer: From Bench to Bedside.
Chen M; Yang Y; Xu K; Li L; Huang J; Qiu F
Front Endocrinol (Lausanne); 2020; 11():573. PubMed ID: 32982970
[TBL] [Abstract][Full Text] [Related]
15. Androgen Receptor as an Emerging Feasible Biomarker for Breast Cancer.
You CP; Leung MH; Tsang WC; Khoo US; Tsoi H
Biomolecules; 2022 Jan; 12(1):. PubMed ID: 35053220
[TBL] [Abstract][Full Text] [Related]
16. Androgen receptor in breast cancer: A wolf in sheep's clothing? A lesson from prostate cancer.
Salvi S; Bonafè M; Bravaccini S
Semin Cancer Biol; 2020 Feb; 60():132-137. PubMed ID: 31002873
[TBL] [Abstract][Full Text] [Related]
17. Chemical degrader enhances the treatment of androgen receptor-positive triple-negative breast cancer.
Wu Y; Xue J; Li J
Arch Biochem Biophys; 2022 May; 721():109194. PubMed ID: 35337811
[TBL] [Abstract][Full Text] [Related]
18. Androgen Receptor in Breast Cancer-Clinical and Preclinical Research Insights.
Anestis A; Zoi I; Papavassiliou AG; Karamouzis MV
Molecules; 2020 Jan; 25(2):. PubMed ID: 31952272
[TBL] [Abstract][Full Text] [Related]
19. The androgen receptor as a surrogate marker for molecular apocrine breast cancer subtyping.
Lakis S; Kotoula V; Eleftheraki AG; Batistatou A; Bobos M; Koletsa T; Timotheadou E; Chrisafi S; Pentheroudakis G; Koutras A; Zagouri F; Linardou H; Fountzilas G
Breast; 2014 Jun; 23(3):234-43. PubMed ID: 24703723
[TBL] [Abstract][Full Text] [Related]
20. Androgen blockade based clinical trials landscape in triple negative breast cancer.
Shi Y; Yang F; Huang D; Guan X
Biochim Biophys Acta Rev Cancer; 2018 Dec; 1870(2):283-290. PubMed ID: 29807045
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]